Archive for the ‘Lyme’ Category

Study: Controlled Burns Reduce Ticks, Lyme Disease

https://www.bayjournal.com/news/wildlife_habitat/study-controlled-burns-reduce-ticks-lyme-disease/article

Study: Controlled burns reduce ticks, Lyme disease

By Ad Crable

Jan. 13, 2023

Prescribed fire

A prescribed fire takes place at the Arboretum at Penn State. (Courtesy of the Arboretum at Penn State)

As tick-borne Lyme disease continues to spread in Pennsylvania and other Chesapeake Bay drainage states, a new study suggests more use of prescribed burns on public and private forests could help reduce both the numbers of ticks and incidence of the disease.

In a paper published in Ecological Applications, researchers from Penn State, the U.S. Forest Service and New Jersey Department of Environmental Protection said the increased use of prescribed fire by forest managers to control invasive plants, improve wildlife habitat and restore ecosystem health can also help knock down the tick problem.  (See link for article)

________________

**Comment**

For more:

    Lyme Misinformation Has Physicians Searching For Guidance

    https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u

    Lyme disease misinformation has physicians searching for guidance

    Carl Tuttle

    Hudson, NH, United States

    JAN 20, 2023 — 

    It appears that the CDC has partnered with Mathematica to start working on the “disinformation campaign” for the upcoming Lyme vaccine brought to you by Pfizer who paid the the largest health care fraud settlement in history for fraudulent marketing. $2.3 Billion!

    Why not start an email campaign and tell these folks how Lyme disease has impacted your life?

    Email addresses:

    Arnold Chen achen@mathematica-mpr.com
    Frederick Chen frederick.chen@ama-assn.org
    Grace Marx gmarx@cdc.gov
    Sara Berg sara.berg@ama-assn.org

    Email to Arnold Chen, Senior Researcher at Mathematica…

    ———- Original Message ———-
    From: CARL TUTTLE <runagain@comcast.net>
    To: “achen@mathematica-mpr.com” <achen@mathematica-mpr.com>, “info@mathematica-mpr.com” <info@mathematica-mpr.com>
    Cc: “grace.marx@cuanschutz.edu” <grace.marx@cuanschutz.edu>, “lwx1@cdc.gov” <lwx1@cdc.gov>, “frederick.chen@ama-assn.org” <frederick.chen@ama-assn.org>
    Date: 01/19/2023 5:53 PM
    Subject: Lyme disease misinformation has physicians searching for guidance

    JAN 12, 2023

    Lyme disease misinformation has physicians searching for guidance
    https://www.ama-assn.org/delivering-care/public-health/lyme-disease-misinformation-has-physicians-searching-guidance

    “False and misleading information about the diagnosis and treatment of Lyme disease is spreading and creating confusion for both physicians and patients,” Dr. Chen added. The report conducted with the CDC and Mathematica Policy Research is just the start and “will highlight some of the disinformation that patients with persistent, medically unexplained symptoms attributed to Lyme disease have been exposed to and how some physicians respond to that,” he said.

    Mathematica
    Princeton, NJ
    Attn: Arnold Chen, Senior Researcher

    Dear Dr. Chen,

    Could you please answer the following questions:

    1. Will the CDC and Mathematica report include the following reference:

    European Neurology 1995

    Seronegative Chronic Relapsing Neuroborreliosis
    https://www.karger.com/Article/Abstract/117104
    Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

    Abstract

    We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
    ____________________________________________

    2. Will your report include the following references of seronegative Lyme disease:

    Seronegativity in Lyme borreliosis and Other Spirochetal Infections (16 September 2003)
    https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

    3. Will the CDC and Mathematica report include the following:

    Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 References)
    https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

    4. Were you aware that the Western blot reporting criteria was manipulated in 1995 to facilitate vaccine development? (Dearborn Conference)

    That manipulation led to a reduction in diagnostic success rate to 31% as reported by Dr. Paul Fawcett during the 1995 Rheumatology Symposia:
     
    1995 Rheumatology Symposia Abstract# 1254 Dr. Paul Fawcett et al.

    See abstract here

    Faulty misleading FDA approved antibody tests cannot be used to gauge treatment failure or success and are absolutely essential for hiding an antibiotic resistant/tolerant superbug.

    What we have been dealing with here Dr. Chen (based on all the suppressed evidence I have shared with you) is deliberate mismanagement of a disease. A chronic relapsing seronegative disease does not fit the vaccine model and that is the root of the disinformation perpetuated by the CDC for three decades. Now you have been informed. What will you do with this information?

    A response to this inquiry is requested.

    Carl Tuttle
    Independent Researcher
    Hudson, NH

    “It is difficult to get a man to understand something when his salary depends upon his not understanding it” -Upton Sinclair, American novelist and social reformer

    Cc:

    -Frederick Chen, MD, chief health and science officer at the AMA

    -Grace Marx, MD, MPH, medical epidemiologist with the Bacterial Diseases Branch at CDC’s Division of Vector-Borne diseases

    ________________

    For more:

    How Common is Lyme Carditis in Patients Referred For Pacemaker Implantation?

    https://danielcameronmd.com/lyme-carditis-in-patients-pacemaker-implantation/

    HOW COMMON IS LYME CARDITIS IN PATIENTS REFERRED FOR PACEMAKER IMPLANTATION?

    Doctor looking at ECG machine to diagnose lyme carditis in patient admitted for a pacemaker.

    Atrioventricular blocks (AVBs) due to an infection have rarely been reported. However, “Borrelia burgdorferi is increasingly noted as responsible for a considerable number of infection-related AVBs, and AVBs have been reported as the most common clinical presentation of [Lyme carditis],” according to the authors of a newly published study.

    By Dr. Daniel Cameron

    In the study “Prevalence of Lyme Carditis in Patients with Atrioventricular Blocks,” Kaczmarek and colleagues aim to identify patients in whom Lyme carditis (LC) should be considered as the underlying cause of AV conduction disturbances.¹

    Investigators examined 130 patients with AVB who had been consecutively admitted over a 12-month period, to the Department of Electrocardiology Medical University of Lodz, Poland, for implantation of a permanent pacemaker.

    All of the patients underwent serological testing for Borrelia burgdorferi sensu lato (Bbsl).

    The majority of the patients had arterial hypertension (64.6%), approximately 1 in 4 had ischemic heart disease (26.2%) and 1 in 5 suffered from diabetes (19.9%) and dyslipidemia (21.9%).
    “Atrial fibrillation was reported by 23 patients (17.7%). One sixth (22; 16.9%) of the patients had a history of heart failure, including 13 individuals (10.0%) with a reduced and mildly reduced ejection fraction,” according to Kaczmarek et al.

    Lyme carditis in patients admitted for pacemaker implants

    Out of the 130 patients, 30 (23.1%) individuals tested positive for Borrelia burgdorferi, the causative agent of Lyme disease. “IgM seropositivity indicating acute phase was found in 16 of them (12.3%), which together with clinical scenario of AVB led to initial diagnosis of LC.”

    The authors found that Lyme carditis was assumed as the initial diagnosis in 16 patients based on ABV and IgM Bbsl seropositivity.

    In 10% of these patients, Lyme carditis was identified as the potential cause of AV conduction disturbances.

    “In clinical practice, patients with [Lyme carditis] diagnosis at admission typically receive antibiotics, which seem to be highly effective in resolving advanced atrioventricular conduction abnormalities.”

    The clinical characteristics were similar between the Lyme carditis and non-LC group. Nearly 40% of patients in both groups had complete heart block, while second-degree AVB was identified in over 50% of patients in the LC and non-LC group.

    The patients did not exhibit any signs or symptoms of acute myocarditis or endocarditis. “Therefore, the atrioventricular conduction disturbances were found to be the unique clinical presentation of [Lyme carditis] in our study group.”

    Additionally, Lyme carditis patients were younger and more often exhibited constitutional symptoms of infection, along with fluctuating atrioventricular conduction abnormalities.

    Authors Conclude:

    • “Lyme carditis should be considered as the initial diagnosis in a relatively high number of patients (8%) admitted with atrioventricular blocks for a permanent pacemaker implantation.”
    • “The prevalence of LC was even higher (12%) in the patients without obvious causes of a cardiac conduction system dysfunction.”
    • “We confirmed that the fluctuating nature of AVBs reported previously in case reports should be taken into account as a strong predictor of LC in patients referred for a pacemaker implantation.”
    • “We suggest that atrioventricular conduction behavior observed on ECG monitoring should be included in the diagnostic process of AVBs that could be potentially [Lyme carditis-related].”

    Lyme Detox Webinar Tonight

    https://rawlsmd.com/webinars/lyme-detox/?utm_source=Klaviyo&utm_medium=email&utm_campaign=webinar

    Lyme Detox

    How to Use Detox as an Effective Tool for Lyme Recovery

    • Wed. Jan. 18, 2023
    • 8 PM EST

    Live Webinar + Q&A: Lyme Detox

    Chronic Lyme patients know that following the right detoxification plan is vital to supporting the body’s ability to heal and avoiding or minimizing Herxheimer reactions that commonly occur with microbial die-off. But finding the right plan amidst all the products and programs out there can be downright confusing.

    So which detox methods are best for removing toxins like mold, heavy metals, and bacterial die-off from the body, and when is the right time to put a Lyme detox protocol into action? 

    Join a live webinar with Dr. Bill Rawls, author of the bestselling book Unlocking Lyme, as he shares a practical and sustainable approach to Lyme detox at a cellular and whole-body level. He’ll discuss his insights on the safest and most effective ways to naturally minimize the inflow of toxins, maximize the outflow, and speed your recovery.

    PLUS: Don’t miss an exclusive gift for webinar attendees, and have your questions ready for a LIVE Q&A on Lyme detox with Dr. Rawls.

    In This Webinar, Dr. Rawls Will Discuss:

    *Environmental toxins that can overtax the body

    *How MTHFR mutations and other genetic factors inhibit your ability to flush toxins

    *Lifestyle and diet changes that enhance your body’s natural detoxification processes

    *The best time to detox in order to optimize your Lyme treatment regimen

    *The best herbs and natural supplements to increase toxin outflow

    *Numerous insights during the live Q&A with Dr. Rawls

    RESERVE MY SEAT »

    __________________

    For more:

    How the Industrial Medical Complex Promotes Disinformation to Perpetuate an Existing Dogma

    Lyme/MSIDS has been in a never-ending time warp. For patients who are educated on the horrific backstory, they were completely aware of COVID madness before most of the public.  The same tricks have been used.  The same fraud, corruption, and lies Lymeland has been dealing with for over 40 years are now finally being seen and felt by the general pubic.

    https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf

    (84%) had no findings of active Lyme disease??

    Carl Tuttle

    Hudson, NH, United States

    JAN 17, 2023 — 

    Here is how the industrial medical complex promotes the disinformation to perpetuate an existing dogma. You won’t find any of my references in Dr. Auwaerter’s publication.  Why is that???

    Inquiry to Dr. Paul G. Auwaerter

    ———- Original Message ———-
    From: CARL TUTTLE <runagain@comcast.net>
    To: “pauwaert@jhmi.edu” <pauwaert@jhmi.edu>
    Cc: “Takaaki-kobayashi@uiowa.edu” <Takaaki-kobayashi@uiowa.edu>, “yhiggins@jhmi.edu” <yhiggins@jhmi.edu>, “mmelia4@jhmi.edu” <mmelia4@jhmi.edu>, “mwoolley@researchamerica.org” <mwoolley@researchamerica.org>, “jalpert@shc.arizona.edu” <jalpert@shc.arizona.edu>
    Date: 01/16/2023 2:57 PM
    Subject: Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease
     
    The American Journal of Medicine April 2022

    Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease (Apr 2022)
    https://www.sciencedirect.com/science/article/pii/S0002934321007920
    Takaaki Kobayashi MD,  Yvonne Higgins MAS, MS  Michael T.Melia MD  Paul G.Auwaerter MD

    Results

    “Of 1261 referred patients, 1061 (84%) had no findings of active Lyme disease…”

    Paul G. Auwaerter MD
    Division of Infectious Diseases
    Department of Medicine
    Johns Hopkins University School of Medicine
    Baltimore, Md

    Dear Dr. Auwaerter,

    I read your abstract with great interest but I must ask the question; how did you determine that 84% had no findings of active Lyme disease? Were these results obtained through serology?

    Seronegative Lyme disease has been reported for years. I have attached a list of publications for your review:

    Seronegativity in Lyme borreliosis and Other Spirochetal Infections
    (16 September 2003)
    https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

    For example:

    European Neurology 1995

    Seronegative Chronic Relapsing Neuroborreliosis
    https://www.karger.com/Article/Abstract/117104
    Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

    Abstract

    We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
    ____________________________________________

    Patients who were featured in the 5min extended trailer for the documentary “Under our Skin” claim the following:

    – Misdiagnosed with Chronic Fatigue Syndrome, Lupus, MS, Fibromyalgia, ALS

    “Under our Skin” extended trailer (5min)
    https://www.youtube.com/watch?v=sxWgS0XLVqw

    ____________________________________________

    Western blot reporting criteria was manipulated in 1995 to facilitate vaccine development. (Dearborn Conference)

    That manipulation led to a reduction in diagnostic success rate to 31% as reported by Dr. Paul Fawcett during the 1995 Rheumatology Symposia:

    1995 Rheumatology Symposia Abstract# 1254 Dr. Paul Fawcett et al.

    View Dr. Paul fawcett’s Abstract 1254 here

    Dr. Fawcett has been the head of the research and clinical immunology laboratories since 1986. In addition, he serves as Chair of the IACUC and is a member of the IRB.

    Source: https://www.nemoursresearch.org/snap/node/11969

    Even more significant is Dennis Parenti’s 1998 vaccine presentation (Lyme.org at 1 hr 9 minutes). Dr. Parenti, medical director of the vaccine trial – the largest Lyme trial in history, discusses the research findings of seronegative Lyme. At 36% it is a common presentation. This proves that a negative western blot is meaningless. Since their patients were culture positive and/or DNA positive for Borrelia infection and western blot negative.
    View Dennis Parenti’s 1998 vaccine presentation slide here

    As you should know Dr. Auwaerter, serology cannot be used to gauge treatment failure or success so I ask the question again: how did you determine that 84% had no findings of active Lyme disease?

    A response to this inquiry is requested.

    Carl Tuttle
    Independent Researcher
    Hudson, NH

    Cc: Joseph Alpert, MD, MACP Editor-in-Chief, The American Journal of Medicine

    Mary Woolley President and CEO of Research!America